Therapy of West Nile virus infection.
Jackson
Alan C
AC
D000328:Adult; D000368:Aged; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D018390:Gene Targeting; D006801:Humans; D007114:Immunization; D007136:Immunoglobulins / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D012254:Ribavirin / Q000627:therapeutic use*; D014901:West Nile Fever / Q000276:immunology / Q000628:therapy* / Q000821:virology; D014902:West Nile virus / Q000276:immunology* / Q000472:pathogenicity
D000998:Antiviral Agents; D007136:Immunoglobulins; D016898:Interferon-alpha; D012254:Ribavirin